IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,852,546 | -18.8% | 1,230,794 | -10.3% | 0.00% | -25.0% |
| Q2 2023 | $14,595,611 | -7.9% | 1,371,768 | -9.0% | 0.00% | -20.0% |
| Q1 2023 | $15,850,390 | +17.6% | 1,506,691 | +38.4% | 0.01% | +25.0% |
| Q4 2022 | $13,483,690 | +27.7% | 1,088,272 | +6.8% | 0.00% | 0.0% |
| Q3 2022 | $10,557,000 | -18.6% | 1,018,938 | -9.4% | 0.00% | -20.0% |
| Q2 2022 | $12,969,000 | -27.8% | 1,124,738 | -21.2% | 0.01% | 0.0% |
| Q1 2022 | $17,967,000 | +5.3% | 1,428,181 | -2.4% | 0.01% | 0.0% |
| Q4 2021 | $17,065,000 | -9.3% | 1,463,491 | +1.6% | 0.01% | -16.7% |
| Q3 2021 | $18,808,000 | +23.7% | 1,440,085 | +21.9% | 0.01% | +20.0% |
| Q2 2021 | $15,202,000 | +14.3% | 1,181,188 | -0.7% | 0.01% | 0.0% |
| Q1 2021 | $13,302,000 | +1.2% | 1,189,795 | +3.1% | 0.01% | 0.0% |
| Q4 2020 | $13,150,000 | +28.0% | 1,154,446 | +1.1% | 0.01% | 0.0% |
| Q3 2020 | $10,273,000 | -9.9% | 1,141,981 | +3.3% | 0.01% | -16.7% |
| Q2 2020 | $11,405,000 | +14.7% | 1,105,073 | +12.1% | 0.01% | 0.0% |
| Q1 2020 | $9,946,000 | -22.0% | 985,678 | +2.9% | 0.01% | -14.3% |
| Q4 2019 | $12,754,000 | +58.8% | 958,154 | +2.4% | 0.01% | +40.0% |
| Q3 2019 | $8,034,000 | -19.0% | 935,770 | +3.2% | 0.01% | -16.7% |
| Q2 2019 | $9,919,000 | -13.8% | 906,657 | +6.6% | 0.01% | -14.3% |
| Q1 2019 | $11,506,000 | +45.3% | 850,374 | +11.2% | 0.01% | +16.7% |
| Q4 2018 | $7,921,000 | -45.2% | 764,529 | -2.3% | 0.01% | -40.0% |
| Q3 2018 | $14,446,000 | +4.6% | 782,524 | +8.3% | 0.01% | 0.0% |
| Q2 2018 | $13,816,000 | +32.0% | 722,555 | +6.5% | 0.01% | +25.0% |
| Q1 2018 | $10,468,000 | +8.7% | 678,398 | +5.6% | 0.01% | 0.0% |
| Q4 2017 | $9,626,000 | -4.5% | 642,120 | +0.4% | 0.01% | -11.1% |
| Q3 2017 | $10,082,000 | -16.8% | 639,299 | -0.4% | 0.01% | -18.2% |
| Q2 2017 | $12,120,000 | +5.9% | 641,947 | -4.3% | 0.01% | 0.0% |
| Q1 2017 | $11,447,000 | +21.4% | 670,966 | +8.8% | 0.01% | +10.0% |
| Q4 2016 | $9,429,000 | +7.4% | 616,639 | +11.6% | 0.01% | 0.0% |
| Q3 2016 | $8,778,000 | +54.0% | 552,724 | +26.8% | 0.01% | +42.9% |
| Q2 2016 | $5,700,000 | +24.5% | 435,942 | +4.2% | 0.01% | +16.7% |
| Q1 2016 | $4,578,000 | -3.6% | 418,403 | +2.1% | 0.01% | 0.0% |
| Q4 2015 | $4,750,000 | +21.0% | 409,780 | +8.8% | 0.01% | 0.0% |
| Q3 2015 | $3,924,000 | -17.7% | 376,498 | -4.7% | 0.01% | -14.3% |
| Q2 2015 | $4,766,000 | -12.7% | 395,135 | +15.8% | 0.01% | -12.5% |
| Q1 2015 | $5,462,000 | +9.6% | 341,336 | +5.0% | 0.01% | +14.3% |
| Q4 2014 | $4,982,000 | +22.6% | 325,133 | +3.7% | 0.01% | 0.0% |
| Q3 2014 | $4,063,000 | -14.2% | 313,556 | +1.5% | 0.01% | -12.5% |
| Q2 2014 | $4,738,000 | +30.8% | 309,061 | +5.2% | 0.01% | +33.3% |
| Q1 2014 | $3,621,000 | +24.3% | 293,861 | +17.2% | 0.01% | 0.0% |
| Q4 2013 | $2,913,000 | +3.8% | 250,832 | +4.3% | 0.01% | 0.0% |
| Q3 2013 | $2,806,000 | +23.3% | 240,594 | +8.3% | 0.01% | +20.0% |
| Q2 2013 | $2,276,000 | – | 222,185 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |